Sign in

CIK 0001658551

  • Non-accelerated filer
  • Smaller reporting company

Amylyx Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464600503
Phone
+1 617-682-0917
Business address
55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
  1. 4 Grant or award Chief Legal Officer acquired 80,560 shares (grant or award)
  2. 4 Grant or award Co-Chief Executive Officer acquired 179,850 shares (grant or award)
  3. 4 Grant or award Chief Medical Officer acquired 96,910 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market sale Co-Chief Executive Officer sold 4,135 shares at $18.73 ($77,440)
  7. 4 Open-market sale Co-Chief Executive Officer sold 4,135 shares at $18.73 ($77,440)
  8. 4 Open-market sale Chief Financial Officer sold 1,792 shares at $18.73 ($33,560)
  9. 4 Open-market sale Chief Legal Officer sold 1,540 shares at $18.73 ($28,841)
  10. 4 Grant or award Chief Financial Officer acquired 40,000 shares (grant or award)
  11. 4 Grant or award Co-Chief Executive Officer acquired 126,667 shares (grant or award)
  12. 4 Grant or award Co-Chief Executive Officer acquired 126,667 shares (grant or award)
  13. 4 Grant or award Chief Legal Officer acquired 36,667 shares (grant or award)
  14. 4 Open-market sale Chief Legal Officer sold 2,838 shares at $18.76 ($53,231)
  15. 4 Gift Director gave 9,100 shares (gift)
  16. 4 Gift Director gave 94,350 shares (gift)
  17. 4 Open-market sale Co-Chief Executive Officer sold 5,841 shares at $16.33 ($95,372)
  18. 4 Open-market sale Chief Financial Officer sold 2,716 shares at $16.33 ($44,347)
  19. 4 Open-market sale Co-Chief Executive Officer sold 5,841 shares at $16.33 ($95,372)
  20. 4 Open-market sale Chief Medical Officer sold 2,812 shares at $16.33 ($45,915)

Page 6 of 11 · 207 filings